Related references
Note: Only part of the references are listed.Suicidal Thoughts and Behavior With Antidepressant Treatment Reanalysis of the Randomized Placebo-Controlled Studies of Fluoxetine and Venlafaxine
Robert D. Gibbons et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
Trends in Depression and Antidepressant Prescribing in Children and Adolescents: A Cohort Study in The Health Improvement Network (THIN)
Linda P. M. M. Wijlaars et al.
PLOS ONE (2012)
Are adolescents dying by suicide taking SSRI antidepressants? A review of observational studies
Michael Dudley et al.
AUSTRALASIAN PSYCHIATRY (2010)
Lifetime Prevalence of Mental Disorders in U.S. Adolescents: Results from the National Comorbidity Survey Replication-Adolescent Supplement (NCS-A)
Kathleen Ries Merikangas et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2010)
News Coverage of FDA Warnings on Pediatric Antidepressant Use and Suicidality
Colleen L. Barry et al.
PEDIATRICS (2010)
Antidepressants and Suicide Risk: How Did Specific Information in FDA Safety Warnings Affect Treatment Patterns?
Susan H. Busch et al.
PSYCHIATRIC SERVICES (2010)
Patterns of antidepressant use in Quebec children and adolescents: Trends and predictors
Marie Tournier et al.
PSYCHIATRY RESEARCH (2010)
Decrease in suicide among the individuals treated with antidepressants: a controlled study of antidepressants in suicide, Sweden 1995-2005
G. Isacsson et al.
ACTA PSYCHIATRICA SCANDINAVICA (2009)
Persisting Decline in Depression Treatment After FDA Warnings
Anne M. Libby et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Selection criteria and generalizability within the counterfactual framework: explaining the paradox of antidepressant-induced suicidality?
Herbert I. Weisberg et al.
CLINICAL TRIALS (2009)
Suicidal Events in the Treatment for Adolescents With Depression Study (TADS)
Benedetto Vitiello et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Effects of food and drug administration warnings on antidepressant use in a national sample
Mark Olfson et al.
ARCHIVES OF GENERAL PSYCHIATRY (2008)
Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults
Laurence Y. Katz et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2008)
Suicide trends among youths aged 10 to 19 years in the United States, 1996-2005
Jeffrey A. Bridge et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
The population impact on incidence of suicide and non-fatal self harm of regulatory action against the use of selective serotonin reuptake inhibitors in under 18s in the United Kingdom: ecological study
Benedict W. Wheeler et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents
Robert D. Gibbons et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs
Anne M. Libby et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States
Charles B. Nemeroff et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Antidepressants in children and adolescents - changes in utilisation after safety warnings
Angela J. Dean et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Antidepressants in child and adolescent depression: where are the bugs?
C. Moreno et al.
ACTA PSYCHIATRICA SCANDINAVICA (2007)
The relationship between antidepressant prescription rates and rate of early adolescent suicide
Robert D. Gibbons et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Antidepressants and youth suicide in New York City, 1999-2002
Andrew C. Leon et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2006)
Do antidepressants precipitate youth suicide?
Lars Sondergard et al.
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY (2006)
A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression
KD Wagner et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2006)
ACNP task force report on SSRIs and suicidal behavior in youth
JJ Mann et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Suicide risk during antidepressant treatment
GE Simon et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder
AL von Knorring et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2006)
Utah youth suicide study: Psychological autopsy
M Moskos et al.
SUICIDE AND LIFE-THREATENING BEHAVIOR (2005)
Antidepressant drug use and suicide prevention
G Isacsson et al.
INTERNATIONAL REVIEW OF PSYCHIATRY (2005)
Selective serotonin reuptake inhibitor antidepressants and the risk of suicide: a controlled forensic database study of 14,857 suicides
G Isacsson et al.
ACTA PSYCHIATRICA SCANDINAVICA (2005)
Anti-depressants, suicide, and drug regulation
J Ludwig et al.
JOURNAL OF POLICY ANALYSIS AND MANAGEMENT (2005)
Effects of the committee on safety of medicines advice on antidepressant prescribing to children and adolescents in the UK
ML Murray et al.
DRUG SAFETY (2005)
Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data
CJ Whittington et al.
LANCET (2004)
Relationship between antidepressant medication treatment and suicide in adolescents
M Olfson et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
Youth risk behavior surveillance - United States, 2001
JA Grunbaum et al.
JOURNAL OF SCHOOL HEALTH (2002)
Fluoxetine for acute treatment of depression in children and adolescents: A placebo-controlled, randomized clinical trial
GJ Emslie et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2002)
Suicide prevention - a medical breakthrough?
G Isacsson
ACTA PSYCHIATRICA SCANDINAVICA (2000)
Share Paper
